Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for ...

Find out the best way to find the right CDMO for your biotech. Experts shared some advice to help companies through the ...

Having already worked with clinical trial sites in more than 14 states, CTAC will now take its work nationwide, the ...

"We are proud to partner with Kaida BioPharma on the development of KAD101,” said Prof. Vladas Algirdas Bumelis, CEO and ...

President Trump announced a plan to reduce prescription drug prices by implementing a most-favored-nation policy with the ...

NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Questex's Fierce Biotech today announces the finalists of the second annual Fierce ...

In the headquarters of a mid-sized pharmaceutical company preparing for its first product launch, a scene once considered ...

With long development timelines and high burn rates, biotech companies must navigate capital markets with precision.

Explore Novotech CEO John Moller's insights on the company's global expansion, commitment to diversity, and innovative ...

A shift is evident in the healthcare and biotech industry that is steadily moving toward a digital future. A future where ...

TrialWire™ is the risk-share pay-per-enrolled AI and algorithm-powered patient recruitment Platform built on Salesforce ...

Samsung Biologics, the biotech arm of Samsung Group, announced Thursday that it will spin off its biosimilar operations into ...